Geron Corporation (GERN)
NASDAQ: GERN · Real-Time Price · USD
1.200
-0.030 (-2.44%)
At close: Oct 17, 2025, 4:00 PM EDT
1.220
+0.020 (1.67%)
After-hours: Oct 17, 2025, 7:52 PM EDT
Geron Revenue
Geron had revenue of $49.04M in the quarter ending June 30, 2025, with 5,459.64% growth. This brings the company's revenue in the last twelve months to $164.45M, up 11,877.20% year-over-year. In the year 2024, Geron had annual revenue of $76.99M with 32,386.92% growth.
Revenue (ttm)
$164.45M
Revenue Growth
+11,877.20%
P/S Ratio
4.85
Revenue / Employee
$718,109
Employees
229
Market Cap
765.62M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 76.99M | 76.76M | 32,386.92% |
Dec 31, 2023 | 237.00K | -359.00K | -60.23% |
Dec 31, 2022 | 596.00K | -797.00K | -57.21% |
Dec 31, 2021 | 1.39M | 1.14M | 450.59% |
Dec 31, 2020 | 253.00K | -207.00K | -45.00% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 92.15B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
GERN News
- 4 days ago - Geron Corporation Announces Executive Leadership Transitions and Appointments - GlobeNewsWire
- 8 days ago - Making Money In Biotech Stocks - Seeking Alpha
- 4 weeks ago - Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - Geron to Participate in the 2025 Wells Fargo Healthcare Conference - Business Wire
- 2 months ago - Geron Corporation Investors: Company Investigated by the Portnoy Law Firm - GlobeNewsWire
- 2 months ago - Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 2 months ago - Geron: I Think We've Seen This Movie Before - Seeking Alpha
- 2 months ago - Geron Corporation (GERN) Q2 2025 Earnings Call Transcript - Seeking Alpha